相关实验视频

Updated: Jul 3, 2026

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
06:38

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

评估索拉费尼布 (SORA-2) 作为第二线治疗不可切除的肝细胞癌:欧洲回顾性多中心研究

Christian Möhring1,2, Moritz Berger3,4, Farsaneh Sadeghlar1

  • 1Department of Medicine I, University Hospital of Bonn, Venusberg-Campus 1, 53127 Bonn, Germany.

Cancers
|March 28, 2025
PubMed
概括

晚期肝细胞癌 (HCC) 中二线索拉芬尼的治疗结果与肝功能良好患者的其他治疗方法相似. 需要进一步的研究来确定用于优化HCC治疗算法的响应预测因子.

关键词:
肝细胞癌是肝细胞癌.肝癌 肝癌 是一种肝癌.作为第二线疗法.索拉芬尼布 (Sorafenib) 是一个

更多相关视频

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma09:11

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

相关概念视频

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...